Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Impact of ibrutinib dose intensity on patient outcomes in previously treated Waldenstrom macroglobulinemia HAEMATOLOGICA Castillo, J. J., Gustine, J. N., Meid, K., Dubeau, T. E., Xu, L., Yang, G., Hunter, Z. R., Advani, R., Palomba, L., Treon, S. P. 2018; 103 (10): E466–E468
View details for PubMedID 29773590